UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

Diabetic medicine, 2007-10, Vol.24 (10), p.1112-1120

2007

Volltextzugriff (PDF)

Identifying potentially cost effective chronic care programs for people with COPD

International journal of chronic obstructive pulmonary disease, 2009, Vol.4 (default), p.87-100

2009

Volltextzugriff (PDF)

The Health Technology Assessment-disease management instrument reliably measured methodologic quality of health technology assessments of disease management

Journal of clinical epidemiology, 2004-09, Vol.57 (9), p.881-888

2004

Volltextzugriff (PDF)

Primary Treatments for Intermediate-Risk Prostate Cancer: a Cost-Effectiveness and Value-of-Information Analysis

Value in health, 2014-11, Vol.17 (7), p.A323-A323

2014

Volltextzugriff (PDF)

Economic evaluation of nurse practitioners versus GPs in treating common conditions

British journal of general practice, 2010-01, Vol.60 (570), p.e28-e35

2010

Volltextzugriff (PDF)

Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

Value in health, 2014-11, Vol.17 (7), p.A624-A624

2014

Volltextzugriff (PDF)

Combining Headroom and Return on Investment Analysis To Rank Potential Commercial Value of Six Medical Devices in Development

Value in health, 2014-11, Vol.17 (7), p.A443-A443

2014

Volltextzugriff (PDF)

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Value in health, 2014-11, Vol.17 (7), p.A644-A644

2014

Volltextzugriff (PDF)

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

Value in health, 2014-11, Vol.17 (7), p.A323-A323

2014

Volltextzugriff (PDF)

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Value in health, 2014-11, Vol.17 (7), p.A640-A640

2014

Volltextzugriff (PDF)

Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure (the TEHAF-study)

European heart journal, 2013-08, Vol.34 (suppl 1), p.P3346-P3346

2013

Volltextzugriff (PDF)

Cost-minimisation in vitamin B12 deficiencies: expensive diagnostics can reduce spending

Netherlands journal of medicine, 2013-06, Vol.71 (5), p.274-275

2013

Volltextzugriff (PDF)

Quick remedies for improving diabetes care: A contradiction in terms

Primary care diabetes, 2007-12, Vol.1 (4), p.213-214

2007

Volltextzugriff (PDF)

Return on Investment van disease management programma’s

TSG : tijdschrift voor gezondheidswetenschappen, 2008-05, Vol.86 (5), p.231-233

2008

Volltextzugriff (PDF)

Participation of general practitioners in disease management: experiences from The Netherlands

International journal of integrated care, 2002-03, Vol.2 (1), p.e24-e24

2002

Volltextzugriff (PDF)

427P Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?

Annals of oncology, 2022-11, Vol.33, p.S1607

2022

Volltextzugriff (PDF)

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

JCO oncology practice, 2024-04, Vol.20 (4), p.572

2024

Volltextzugriff (PDF)

Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach

International journal of technology assessment in health care, 2008-10, Vol.24 (4), p.459-464

2008

Volltextzugriff (PDF)

Precision Medicine 2.0: The Rise of Glocal Innovation, Superconnectors, and Design Thinking

Omics (Larchmont, N.Y.), 2016-09, Vol.20 (9), p.493

2016

Volltextzugriff (PDF)

PIN90 HEALTH-ECONOMIC MODELLING TO INFORM PRIVATE SECTOR INVESTMENT IN INFECTIOUS DISEASE TREATMENTS IN MIDDLE-INCOME COUNTRIES: THE CASE OF TUBERCULOSIS

Value in health, 2019-05, Vol.22, p.S209-S209

2019

Volltextzugriff (PDF)

Is it economically viable to employ the nurse practitioner in general practice?

Journal of clinical nursing, 2011-02, Vol.20 (3-4), p.518-529

2011

Volltextzugriff (PDF)

An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics"

Omics (Larchmont, N.Y.), 2015-08, Vol.19 (8), p.435

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Unrelated Umbilical Cord Blood vs. HLA Haploidentical Related Bone Marrow Transplant: Evidence from BMT CTN 1101

Transplantation and cellular therapy, 2023-04, Vol.29 (7), p.464.e1-464.e8

2023

Volltextzugriff (PDF)

PS2-12: How to Move From Belief to Proof? Economic Evaluation of Care Programs for Chronically Ill

Clinical medicine & research, 2010-03, Vol.8 (1), p.52-52

2010

Volltextzugriff (PDF)

An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology, Gaziantep, Turkey, May 5-7, 2016

Omics (Larchmont, N.Y.), 2016-04, Vol.20 (4), p.259

2016

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(25)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Internal Medicine
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Cost-Benefit Analysis
(5)
Aged
(4)
Disease Management
(4)
Medicin Och Hälsovetenskap
(3)
Middle Aged
(3)
Models, Economic
(3)
Adult
(2)
Biological And Medical Sciences
(2)
Biotechnology & Applied Microbiology
(2)
Cost Analysis
(2)
Decision Making
(2)
Endocrinology & Metabolism
(2)
Female
(2)
Genetics & Heredity
(2)
Health Care Costs
(2)
Health Care Sciences & Services
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

Identifying potentially cost effective chronic care programs for people with COPD

The Health Technology Assessment-disease management instrument reliably measured methodologic quality of health technology assessments of disease management

Primary Treatments for Intermediate-Risk Prostate Cancer: a Cost-Effectiveness and Value-of-Information Analysis

Economic evaluation of nurse practitioners versus GPs in treating common conditions

Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

Combining Headroom and Return on Investment Analysis To Rank Potential Commercial Value of Six Medical Devices in Development

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure (the TEHAF-study)

Cost-minimisation in vitamin B12 deficiencies: expensive diagnostics can reduce spending

Quick remedies for improving diabetes care: A contradiction in terms

Return on Investment van disease management programma’s

Participation of general practitioners in disease management: experiences from The Netherlands

427P Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach

Precision Medicine 2.0: The Rise of Glocal Innovation, Superconnectors, and Design Thinking

PIN90 HEALTH-ECONOMIC MODELLING TO INFORM PRIVATE SECTOR INVESTMENT IN INFECTIOUS DISEASE TREATMENTS IN MIDDLE-INCOME COUNTRIES: THE CASE OF TUBERCULOSIS

Is it economically viable to employ the nurse practitioner in general practice?

An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics"

Cost-Effectiveness of Unrelated Umbilical Cord Blood vs. HLA Haploidentical Related Bone Marrow Transplant: Evidence from BMT CTN 1101

PS2-12: How to Move From Belief to Proof? Economic Evaluation of Care Programs for Chronically Ill

An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology, Gaziantep, Turkey, May 5-7, 2016

Suchergebnisse filtern